Categories: DeliveryDevelopmentDrugTechnology
PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapies with minimally-invasive delivery technology to treat major eye diseases. Our mission is to develop life-changing solutions for patients with diseases leading to sight loss.
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| 28.02.2024 | PulseSight Therapeutics Raises Seed Funding | PulseSight Therapeutics, a Paris, France-based ophthalmology biotech company, raised an undisclosed amount in Seed funding.
The round was led by Pureos Bioventures and ND Capital, with participation from Korea Investment Partners.
The compa... |
Reviews 0
